Chiung-Yu Huang, Ph.D.
Mathematical Statistician
Interests
Survival analysis; statistical models for multiple event data; longitudinal data analysis; epidemiological studies
Additional Information
Curriculum Vitae (PDF)
Selected Statistical Publications
Luo X, Huang CY, Wang L. Quantile regression for recurrent gap time data. Biometrics, accepted.
Huang CY and Qin J. Composite partial likelihood estimation for length-biased and right-censored data. Journal of the American Statistical Association, 2012;107,946–957.
Huang CY, Qin J, Follmann DA. A maximum pseudo-profile likelihood estimator for the Cox model with length-biased sampling. Biometrika, 2012;99:199-210.
Huang CY and Qin J. Nonparametric estimation under length-biased sampling. Biometrika, 2011; 98, 177-186.
Huang CY, Luo X, Follmann DA. A model checking method for the proportional hazards model for recurrent gap time data. Biostatistics, 2011; 12:535-547.
Luo X* and Huang CY*. Analysis of recurrent gap time data using the weighted risk set method and the modified within-cluster resampling method. Statistics in Medicine, 2011; 30, 301-311. (*Equal contribution by authors.)
Huang CY, Qin J, Wang MC. Semiparametric analysis for recurrent event data with time-dependent covariates and informative censoring. Biometrics, 2010; 66, 39-49.
Huang CY, Qin J, Follmann DA. Empirical likelihood-based estimation of the treatment effect in a pretest–posttest study. Journal of the American Statistical Association, 2008;103,1270-1280.
Huang CY, Qin J, Zou F. Empirical likelihood-based inference for genetic mixture models. Canadian Journal of Statistics, 2007;35,563-574.
Huang CY, Wang MC, Zhang, Y. Analyzing panel count data with informative observation times. Biometrika, 2006;93:763-775.
Huang CY and Wang MC. Nonparametric estimation of the bivariate recurrence time distribution. Biometrics, 2005;61:392-402.
Huang CY and Wang MC. Joint modeling and estimation for recurrent event processes and failure time data. Journal of the American Statistical Association, 2004;99,1153-1165.
Selected Medical Publications
Waisberg M, Vickers B, Tarasenko T, Scott B, Willcocks L, Molina-Cruz A, Pierce M, Huang CY, Kastenmayer R, Smith K, Barrillas-Mury C, Miller L, Pierce S, Bolland S. Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice. PNAS, 2011; 108(3) 1122-1127.
Sui J, Sheehan J, Huang W, Liddington R. Huang CY, Beigel JH and Marasco WA. Wide prevalence of heterosubtypic broadly neutralizing human anti-Influenza A antibodies. Clinical Infectious Diseases, 2011; 52(8): 1003-1009.
Beigel JH, Voell J, Huang CY, Burbelo PD, Lane HC. Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine. Journal of Infectious Diseases, 2009;200(4):501-509.
Crompton PD, Mircetic M, Weiss G, Baughman A, Huang CY, Topham DJ, Treanor JJ, Sanz I, Lee FE, Durbin AP, Miura K, Narum DL, Ellis RD, Malkin E, Mullen GE, Miller LH, Martin LB, Pierce SK. The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals. Journal of Immunology, 2009;182(5):3318-3326.
Crompton PD, Traore B, Kayentao K, Doumbo S, Ongoiba A, Diakite SA, Krause MA, Doumtabe D, Kone Y, Weiss G, Huang CY, Doumbia S, Guindo A, Fairhurst RM, Miller LH, Pierce SK, Doumbo OK. Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria. Journal of Infectious Diseases, 2008;198(9):1265-1275. (Editorial commentary on pages 1255-1257.)
Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ; Walter Reed Health Care System Influenza Vaccine Consortium. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Archives of Internal Medicine, 2008;168(22):2405-2414. (Editorial commentary on pages 2402-2403.)
Read SW, Lempicki RA, Di Mascio M, Srinivasula S, Burke R, Sachau W, Bosche M, Adelsberger JW, Sereti I, Davey RT Jr, Tavel JA, Huang CY, Issaq HJ, Fox SD, Lane HC, Kovacs JA. CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients. Journal of Infectious Diseases, 2008;198(6):843-850.
back to top